Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “18F-PSMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Early research (Phase 1)Ended earlyNCT03619655
What this trial is testing

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Testing effectiveness (Phase 2)Study completedNCT05095519
What this trial is testing

Hepatocellular Carcinoma Imaging Using PSMA PET/CT

Who this might be right for
Hepatocellular Carcinoma
Peter MacCallum Cancer Centre, Australia 30
Testing effectiveness (Phase 2)Study completedNCT05141760
What this trial is testing

18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients

Who this might be right for
Prostate Cancer
University of Alberta 150
Not applicableStudy completedNCT04000776
What this trial is testing

3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Université de Sherbrooke 100
Very early researchUnknownNCT06462495
What this trial is testing

Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Who this might be right for
Prostate CancerPET/CT
Anhui Provincial Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05155046
What this trial is testing

18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

Who this might be right for
Localized Prostate Cancer
National Cancer Institute (NCI) 130
Not applicableStudy completedNCT06460454
What this trial is testing

PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing

Who this might be right for
Prostate Cancer
Central Hospital, Nancy, France 100
Post-approval studies (Phase 4)Active Not RecruitingNCT05722925
What this trial is testing

Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 50
Post-approval studies (Phase 4)Looking for participantsNCT06099093
What this trial is testing

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate Carcinoma
Brigham and Women's Hospital 30
Not applicableStudy completedNCT05079828
What this trial is testing

Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007

Who this might be right for
Prostate Cancer
Insel Gruppe AG, University Hospital Bern 100
Large-scale testing (Phase 3)Study completedNCT03739684
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Recurrent+1 more
Progenics Pharmaceuticals, Inc. 208
Very early researchUnknownNCT06428708
What this trial is testing

[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Western University 30
Not applicableUnknownNCT05587192
What this trial is testing

Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 57
Large-scale testing (Phase 3)Study completedNCT04644822
What this trial is testing

Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.

Who this might be right for
Prostate Cancer RecurrentRecurrent Prostate Cancer
Centre for Probe Development and Commercialization 100
Testing effectiveness (Phase 2)Study completedNCT04053842
What this trial is testing

Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Neoplasm
Glenn Bauman 16
Not applicableLooking for participantsNCT07011342
What this trial is testing

Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment

Who this might be right for
Prostate Cancer
Hackensack Meridian Health 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03181867
What this trial is testing

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Who this might be right for
Prostate NeoplasmsProstatic CancerProstate Cancer+2 more
National Cancer Institute (NCI) 360
Testing effectiveness (Phase 2)Looking for participantsNCT07285057
What this trial is testing

Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance

Who this might be right for
Prostatic NeoplasmsProstate CancerProstate Adenocarcinoma
Icahn School of Medicine at Mount Sinai 120